Related Experiment Video
Updated: Jul 13, 2026

Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
Sydenham's chorea: a clinical follow-up of 65 patients
Kaan Demiroren1, Haluk Yavuz, Lokman Cam
1Department of Pediatrics, Cagri Tip Merkezi, Elazig, Turkey. kaandemiroren@yahoo.com
Insights
Sydenham's chorea, a childhood rheumatic fever complication, affects many children. This study details clinical findings, treatment, and outcomes, highlighting its continued impact.
Area of Science:
- Neurology
- Pediatrics
- Rheumatology
Background:
- Sydenham's chorea is the most common acquired chorea in childhood, linked to rheumatic fever.
- It presents as a neurological manifestation requiring clinical and laboratory assessment.
Purpose of the Study:
- To present clinical and laboratory findings of Sydenham's chorea patients.
- To analyze patient demographics, symptoms, cardiac involvement, and treatment outcomes.
Main Methods:
- Retrospective study of 65 Sydenham's chorea patients over 7 years.
- Data collected included age of onset, gender, chorea presentation, medical history, echocardiography, MRI, EEG, and treatment.
Main Results:
- Mean onset age 11.7 years; 63% female. Generalized chorea seen in 78.5%.
- Rheumatic fever history in 30.8%; cardiac valve involvement in 70.5%. EEG abnormal in 50%.
- Pimozide was a common treatment; 18.5% needed no drugs. Recovery took 1-6 months for 51.7%. Recurrence rate was 37.9%.
Conclusions:
- Sydenham's chorea remains a significant health concern in Turkey due to its morbidity.
- Early diagnosis and management are crucial for improving patient outcomes and reducing long-term complications.
Abstract:
Sydenham's chorea, the neurological manifestation of rheumatic fever, is the most common acquired chorea of childhood. In this retrospective study, the authors aim to present the clinical and laboratory findings of 65 Sydenham's chorea patients, followed up in a clinic over less than 7 years. The mean age at the onset of the symptoms was 11.7 +/- 2.6 years (range, 6-17 years). Of the patients, 63% were female and 37% were male (male/female: 1.7/1). Chorea was generalized in 78.5% of the patients, right hemichorea in 12.3%, and left hemichorea 9.2%. There was a history of rheumatic fever in 30.8% of the patients. Echocardiographic study showed cardiac valve involvement in 70.5% of 61 patients. Brain magnetic resonance imaging, which was performed on only 18 patients, was evaluated as normal in all. Electroencephalography was also performed on only 18 patients and showed abnormal waves in 50% of them. Pimozide was mostly the first choice of drug therapy. Nevertheless, drug therapy was not needed in 18.5% of the patients. The recovery period of the first attack of the chorea was 1 to 6 months in 51.7% of the patients. The recurrence rate was 37.9%. In conclusion, Sydenham's chorea is still an important health problem in Turkey with respect to its morbidity.
Related Concept Videos
Parkinson's Disease: Overview
Parkinson Disease l: Introduction
Huntington Disease l: Introduction
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease ll: Pathophysiology
Chronic Kidney Disease II: Clinical Manifestations
